What can be added to desvenlafaxine (Pristiq) to help with skin‑picking (excoriation disorder) while the patient is already on 50 mg?

Augmentation Strategy for Excoriation Disorder on Pristiq 50 mg

Add N-acetylcysteine (NAC) 1200-3000 mg/day as first-line augmentation to your current Pristiq regimen for skin-picking disorder. This combination addresses the glutamatergic dysfunction underlying compulsive behaviors while maintaining your current serotonergic/noradrenergic coverage.

Primary Recommendation: N-Acetylcysteine

Start NAC at 1200 mg/day and titrate up to 2400-3000 mg/day over several weeks based on response and tolerability 1. In the largest randomized controlled trial for excoriation disorder, NAC demonstrated significant superiority over placebo, with 47% of patients achieving "much or very much improved" status compared to only 19% on placebo 1. The medication works by restoring extracellular glutamate concentration in the nucleus accumbens, targeting a different neurobiological pathway than your current SNRI 1.

Why NAC First?

• Strong evidence base: The only medication with Level 1 evidence (randomized controlled trial) specifically for excoriation disorder 1
• Excellent tolerability: Well-tolerated with minimal side effects and no significant drug interactions with desvenlafaxine 1
• Complementary mechanism: Addresses glutamatergic dysfunction rather than duplicating serotonergic effects
• Recent systematic review support: Meta-analysis showed large effect sizes for behavioral treatments and pharmacotherapy, with NAC being the best-studied option 2

Dosing Protocol for NAC

1. Week 1-2: 600 mg twice daily (1200 mg/day total)
2. Week 3-4: 1200 mg twice daily (2400 mg/day total)
3. Week 5+: Consider increasing to 1500 mg twice daily (3000 mg/day) if partial response 1
4. Duration: Allow 12 weeks for full therapeutic trial 1

Alternative Augmentation Options

If NAC Fails or Is Not Tolerated

Consider increasing Pristiq dose to 100 mg/day first before adding additional agents 3. The FDA label indicates 50 mg is the recommended dose, but doses up to 400 mg have been studied 3. Since you're on the minimum therapeutic dose, dose optimization is reasonable before polypharmacy.

Second-Line Augmentation: Mirtazapine

Add mirtazapine 15-30 mg at bedtime if NAC proves ineffective 4. A case report demonstrated remarkable response in severe excoriation disorder when mirtazapine was added as augmentation 4. The antihistaminergic properties may specifically help with skin itching and pain that perpetuate the picking cycle 4.

Advantages of mirtazapine augmentation:

• Different mechanism (noradrenergic and specific serotonergic antidepressant with antihistamine effects)
• May address comorbid insomnia or anxiety
• Antihistaminergic effect directly targets pruritus
• No significant drug interactions with desvenlafaxine

Cautions: Monitor for sedation, weight gain, and increased appetite 4

Third-Line: Atypical Antipsychotics

Consider low-dose aripiprazole (2.5-10 mg/day) or olanzapine (2.5-10 mg/day) as augmentation if both NAC and mirtazapine fail 5. These are supported by case series but lack controlled trial data for excoriation disorder specifically 5.

What NOT to Do

Avoid SSRI Augmentation

While SSRIs show promise as monotherapy for excoriation disorder 5, 6, adding an SSRI to your current SNRI (Pristiq) significantly increases serotonin syndrome risk and provides redundant mechanism of action 3. The FDA label explicitly warns about serotonin syndrome with combined serotonergic agents 3.

Avoid Benzodiazepines

Despite anxiety often accompanying skin-picking, benzodiazepines do not address the compulsive nature of excoriation disorder and carry dependence risks 7.

Clinical Monitoring

Track these specific outcomes weekly:

• Frequency of picking episodes (number per day)
• Duration of episodes (minutes)
• Number of active lesions
• Functional impairment (work/social avoidance)
• Time spent on picking-related behaviors

Safety monitoring for NAC: Generally minimal; watch for GI upset (nausea, diarrhea) which is dose-dependent 1

Safety monitoring for Pristiq: Continue monitoring blood pressure and pulse as SNRIs can cause sustained hypertension 8, 3

Important Differential Consideration

Ensure your skin-picking is truly excoriation disorder and not secondary to body dysmorphic disorder (BDD). In BDD, skin picking is driven by attempts to "fix" perceived appearance defects, whereas in excoriation disorder, picking is not primarily appearance-focused 9. This distinction matters because BDD may require higher SSRI/SNRI doses and has different treatment algorithms 9.

Timeline Expectations

• NAC: Expect 8-12 weeks for full response 1
• Mirtazapine: May see effects within 2-4 weeks 4
• Pristiq dose increase: Allow 4-6 weeks at higher dose before adding augmentation 3

The evidence strongly supports trying NAC first given its specific efficacy data for excoriation disorder, excellent safety profile, and complementary mechanism to your current SNRI therapy.